DISCOVERY CAPITAL MANAGEMENT LLC 13D and 13G filings for Alaunos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 12:43 pm Purchase | 2023-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | DISCOVERY CAPITAL MANAGEMENT LLC | 400,186 1.660% | 292,279 (+270.86%) | Filing |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | DISCOVERY CAPITAL MANAGEMENT LLC | 107,907 6.730% | 18,930 (+21.28%) | Filing |
| 2022-02-14 5:06 pm Purchase | 2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | DISCOVERY CAPITAL MANAGEMENT LLC | 88,977 6.170% | 15,678 (+21.39%) | Filing |
| 2021-01-07 4:21 pm Purchase | 2020-12-28 | 13G | Alaunos Therapeutics, Inc. TCRT | DISCOVERY CAPITAL MANAGEMENT LLC | 73,298 5.130% | 73,298 (New Position) | Filing |